• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RASSE:一种基于结构的药物设计新方法。

RASSE: a new method for structure-based drug design.

作者信息

Luo Z, Wang R, Lai L

机构信息

Institute of Physical Chemistry, Peking University, Beijing, P.R. China.

出版信息

J Chem Inf Comput Sci. 1996 Nov-Dec;36(6):1187-94. doi: 10.1021/ci950277w.

DOI:10.1021/ci950277w
PMID:8941995
Abstract

A novel method, RASSE, has been developed to suggest reasonable structures which can fit well to the binding sites of receptors. Molecules are generated by an iterative growing procedure in which atoms are added to existing fragments. Potential ligands are then picked out by special scoring rules. This atomgrowing based method is characterized by combinatorial searching of atom types and conformations. To some extent, it is the computer simulation of combinatorial chemistry. This method has been applied to the design of inhibitors for E. coli dihydrofolate reductase and human phospholipase A2. The results demonstrate that this program is capable of generating reasonable structures, thus proving its power in drug design.

摘要

一种名为RASSE的新方法已被开发出来,用于提出能很好适配受体结合位点的合理结构。分子通过迭代生长过程生成,在此过程中原子被添加到现有的片段上。然后通过特殊的评分规则挑选出潜在的配体。这种基于原子生长的方法的特点是对原子类型和构象进行组合搜索。在某种程度上,它是组合化学的计算机模拟。该方法已应用于大肠杆菌二氢叶酸还原酶和人磷脂酶A2抑制剂的设计。结果表明,该程序能够生成合理的结构,从而证明了其在药物设计中的能力。

相似文献

1
RASSE: a new method for structure-based drug design.RASSE:一种基于结构的药物设计新方法。
J Chem Inf Comput Sci. 1996 Nov-Dec;36(6):1187-94. doi: 10.1021/ci950277w.
2
A new procedure for improving the predictiveness of CoMFA models and its application to a set of dihydrofolate reductase inhibitors.一种提高比较分子场分析(CoMFA)模型预测能力的新方法及其在一组二氢叶酸还原酶抑制剂中的应用。
J Comput Aided Mol Des. 1995 Oct;9(5):396-406. doi: 10.1007/BF00123997.
3
In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.针对野生型和突变型恶性疟原虫二氢叶酸还原酶的计算机筛选。
J Mol Graph Model. 2008 Apr;26(7):1145-52. doi: 10.1016/j.jmgm.2007.10.006. Epub 2007 Oct 18.
4
The structure-based design and synthesis of selective inhibitors of Trypanosoma cruzi dihydrofolate reductase.基于结构的克氏锥虫二氢叶酸还原酶选择性抑制剂的设计与合成。
Bioorg Med Chem Lett. 1999 May 17;9(10):1463-8. doi: 10.1016/s0960-894x(99)00213-9.
5
Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation.
J Med Chem. 1993 Oct 1;36(20):2921-8. doi: 10.1021/jm00072a011.
6
Self-organizing neural networks for modeling robust 3D and 4D QSAR: application to dihydrofolate reductase inhibitors.用于稳健三维和四维定量构效关系建模的自组织神经网络:在二氢叶酸还原酶抑制剂中的应用
Molecules. 2004 Dec 31;9(12):1148-59. doi: 10.3390/91201148.
7
FlexE: efficient molecular docking considering protein structure variations.FlexE:考虑蛋白质结构变异的高效分子对接
J Mol Biol. 2001 Apr 27;308(2):377-95. doi: 10.1006/jmbi.2001.4551.
8
Towards a MIP-based alignment and docking in computer-aided drug design.迈向计算机辅助药物设计中基于MIP的比对和对接
Proteins. 2004 Aug 15;56(3):585-94. doi: 10.1002/prot.20153.
9
Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.1-苯基-6,6-二甲基-1,3,5-三嗪-2,4-二胺衍生物作为大肠杆菌二氢叶酸还原酶抑制剂的配体结合研究、初步构效关系及详细机理表征
Eur J Med Chem. 2015 Oct 20;103:600-14. doi: 10.1016/j.ejmech.2015.08.021. Epub 2015 Sep 5.
10
In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors.基于计算机辅助的以支架为中心的文库的靶点鉴定:1,3,5-三氮杂环庚烷-2,6-二酮作为新型磷脂酶A2抑制剂
J Med Chem. 2006 Nov 16;49(23):6768-78. doi: 10.1021/jm0606589.

引用本文的文献

1
A molecular evolution algorithm for ligand design in DOCK.DOCK 中配体设计的分子进化算法。
J Comput Chem. 2022 Nov 5;43(29):1942-1963. doi: 10.1002/jcc.26993. Epub 2022 Sep 8.
2
Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.从头药物设计的进展:从传统方法到机器学习方法。
Int J Mol Sci. 2021 Feb 7;22(4):1676. doi: 10.3390/ijms22041676.
3
Small proteins: untapped area of potential biological importance.小蛋白质:具有潜在生物学重要性的未开发领域。
Front Genet. 2013 Dec 16;4:286. doi: 10.3389/fgene.2013.00286.
4
From laptop to benchtop to bedside: structure-based drug design on protein targets.从笔记本电脑到台式机再到床边:基于结构的药物设计针对蛋白质靶标。
Curr Pharm Des. 2012;18(9):1217-39. doi: 10.2174/138161212799436386.
5
Development and testing of a de novo drug-design algorithm.
J Comput Aided Mol Des. 2003 Oct;17(10):621-41. doi: 10.1023/b:jcam.0000017362.66268.d5.